|
瘦素与临床疾病的病理生理关系 |
| |
erson JG, Patterson CC, Had
den OR. kptin concentrations in the umbilical vein and relationship to maternal and to maternal and arthropometry. J Record Med,2002,47（8）:645-650.
33 Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor in the abult rat gene in db/db mice. Cell,1996,84（3）:491-495.
34 朱宪彝.临床内分泌学.天津:天津科学技术出版社,1993,421.
35 汪启迪.瘦素与其他相关激素间的互调作用.国外医学・内分泌学分册,1999,19（5）:196.
36 Stefan S, Bo A, Birgitta S, et al. Teptin is a risk maker for first-ever hermorrhagic Stroke in a population-based cohort. Stroke,1999,30（2）:328-337.
37 何静,袁秀珠,尹宁,等.脑卒中急性期患者血清leptin水平及其相关性研究.卒中与神经疾病,2003,10（5）:301.
38 Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, hight density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study. BMJ,1994,309（6946）:11.
39 Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay:a central control of bone mass. Cell,2000,100（2）:197-207.
40 Maor G, Rochwerger M, Segev Y, et al. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res,2002,17（6）:1034-1043.
41 Sato M, Takeda N, Sarui H, et al. Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab,2001,86（11）:5273-5276.
42 Karnafel W. Diabetic cardiomyopathy. Pathophysiology and clinical implications J.Przegl Lek,2000,57（Suppl 4）:9-11.
43 Unger RH, Zhou YT, Qrci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci USA,1999,96（5）:2327-2332.
44 Unger RH. Weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome J. Endocrinology,2003,144（12）:5159-5165.
45 Duprez DA, Debuyzere MI, Rietzschel ER,上一页 [1] [2] [3] [4] [5] [6] [7] [8] 下一页
上一个医学论文： 肺部感染性疾病CT树芽征的病因病理及其诊断价值
下一个医学论文： 水痘免疫球蛋白的临床应用
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 儿科论文 >> 正文